Cargando…
Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2)
The cancer-associated protein Anterior Gradient 2 (AGR2) has been described, predominantly in adenocarcinomas. Increased levels of extracellular AGR2 (eAGR2) have been correlated with poor prognosis in cancer patients, making it a potential biomarker. Additionally, neutralizing AGR2 antibodies showe...
Autores principales: | Garri, Carolina, Howell, Shannon, Tiemann, Katrin, Tiffany, Aleczandria, Jalali-Yazdi, Farzad, Alba, Mario M., Katz, Jonathan E., Takahashi, Terry T., Landgraf, Ralf, Gross, Mitchell E., Roberts, Richard W., Kani, Kian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007958/ https://www.ncbi.nlm.nih.gov/pubmed/29937991 http://dx.doi.org/10.18632/oncotarget.25221 |
Ejemplares similares
-
Differential expression of anterior gradient gene AGR2 in prostate cancer
por: Maresh, Erin L, et al.
Publicado: (2010) -
Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation
por: Maurel, Marion, et al.
Publicado: (2019) -
The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer
por: Fessart, Delphine, et al.
Publicado: (2021) -
Integrative analysis of genomic and transcriptomic alterations of AGR2 and AGR3 in cancer
por: Fessart, Delphine, et al.
Publicado: (2022) -
The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker
por: Salmans, Michael L, et al.
Publicado: (2013)